The federal holiday on the third Monday in February is officially Washington's Birthday, but many states call it Presidents Day. U.S. stock markets, including the NYSE and Nasdaq, are closed in ...
Today is Presidents Day 2026, a federal holiday and bank holiday, and while most schools are closed on Presidents' Day, many grocery stores and retailers open today. But is the stock market open on ...
The S&P 500 (^GSPC 0.94%) inched up 0.05% to 6,836.17 as cooler inflation data steadied sentiment. The Nasdaq Composite (^IXIC 1.02%) slipped 0.22% to 22,546.67, and the Dow Jones Industrial Average ...
Stocks edged lower as investors considered surprisingly strong labor-market data, while AI jitters continued to pressure software and financial shares. Major U.S. benchmarks were mixed most of the day ...
NEW YORK, Feb 6 (Reuters) - An artificial intelligence-driven shakeout in the heavyweight technology sector is set to keep stock investors on edge in the coming week while a barrage of data could ...
The S&P 500 fell for a third day in a row as the week’s selloff broadened beyond tech. The Dow Jones Industrial Average fell 593 points, or 1.2%. The S&P 500 dropped 1.2%. The Nasdaq Composite slid ...
Stock Market News, Feb. 2, 2026: Dow ends up over 500 points, S&P 500 just shy of record after strong manufacturing data; Trump says U.S. and India have reached trade deal; Oil and gold decline.
US stocks dropped Thursday, continuing a recent patch of volatility, as Wall Street grappled with persistent nerves about artificial intelligence and economic data showed the labor market weakened ...
NEW YORK (AP) — The U.S. stock market sank in mixed trading on Tuesday, while gold and silver bounced higher after their latest sell-off. The S&P 500 fell 0.8% and pulled further from its all-time ...
As 2025 wound down, capital markets firms were under the gun to complete key projects before the end of Q4. The committees that govern the US securities information processors (SIPs) were no exception ...
After announcing plans to go public at the top of the year, Eikon Therapeutics has now revealed the proceeds it hopes to pull in from its initial stock offering: $273.5 million. The oncology biotech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results